The VICC.ORG Investigator Directory

Thomas E. Yankeelov, Ph.D.

Ingram Associate Professor of Cancer Research
Associate Professor of Radiology and Radiological Sciences, Biomedical Engineering, Physics and Astronomy, and Cancer Biology
Director of Cancer Imaging Research, Vanderbilt University Institute of Imaging Science (VUIIS)
VICC Member
Researcher

Contact Information:

Vanderbilt University Institute of Imaging Science
1161 21st Ave South, AA 1105 MCN
Nashville, TN 37232-2310
615-322-8354
Fax: 615-322-0734

Profile

The requirement to study cancer in its native environment has lead to the development of imaging technologies that can non-invasively and quantitatively interrogate both primary and metastatic disease. This involves mathematical modeling, application of these models in small animal tumors systems, and ultimately applying the most promising techniques in human breast cancer. The overall goal of Dr. Yankeelov's research is to develop advanced imaging methods for the characterization of human tumors and to evaluate their role as potential surrogate biomarkers of treatment responses and tissue status for use in clinical trials and drug discovery.

Education

  • B.A., Mathematics, University of Louisville
  • M.A., Applied Mathematics, Indiana University
  • M.S., Physics, Indiana University
  • Ph.D., Biomedical Engineering, SUNY at Stony Brook

Research Specialty:

Dr. Yankeelov develops advanced imaging methods for the characterization of human tumors.

Research Description:

The requirement to study cancer in its native environment has lead to the development of imaging technologies that can non-invasively and quantitatively interrogate both primary and metastatic disease. This involves mathematical modeling, application of these models in small animal tumors systems, and ultimately applying the most promising techniques in human breast cancer. The overall goal of Dr. Yankeelov's research is to develop advanced imaging methods for the characterization of human tumors and to evaluate their role as potential surrogate biomarkers of treatment responses and tissue status for use in clinical trials and drug discovery.

Publications:

You do not have JavaScript enabled. This site works better with JavaScript turned on.